HOME >> MEDICINE >> NEWS
Detection of antibodies could identify MS pats who do not respond well to interferon beta

Danish research published in this week's issue of THE LANCET highlights how the detection of antibodies to interferon beta-the first choice treatment for multiple sclerosis patients-could be important in identifying patients who do not respond well to interferon beta, with implications for the provision of alternative drug therapy.

Interferon beta is the first-line treatment for relapsing-remitting multiple sclerosis, but the drug can induce neutralising antibodies against itself, which might reduce its effectiveness. Per Soelberg Sorensen from Copenhagen University Hospital, Denmark, and colleagues measured neutralising antibodies every year for up to five years among 541 patients with multiple sclerosis, randomly selected from all patients who started treatment with interferon beta in Denmark between 1996 and 1999.

The time to first relapse was substantially longer (by 244 days) for patients who were antibody-negative after one year of interferon-beta treatment compared with patients who were antibody-positive. The yearly relapse rate was increased more than 50% in patients who developed antibodies compared with those who did not.

Patients developed neutralising antibodies independent of age, sex, disease duration, and prognosis at the start of treatment. The presence of antibodies did not affect overall disease outcome.

Per Soelberg Sorensen comments: "Our findings suggest that the presence of neutralising antibodies against interferon beta reduces the clinical effect of the drug. In patients who are not doing well on interferon beta, the presence of such antibodies should prompt consideration about a change of treatment to other drug therapies such as glatiramer acetate or mitoxantrone."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
9-Oct-2003


Page: 1

Related medicine news :

1. Detection at a distance for more sensitive MRI
2. Detection of glycoprotein could indentify ovarian and uterine cancers with poor prognosis
3. Detection of bioterrorism viruses brought closer to local sites
4. Detection of glucose intolerance after heart attack
5. Detection of glucose intolerance after heart attack could identify risk of cardiovascular disease
6. Millions Of Americans With Glaucoma Could Save Sight With Early Detection, Treatment
7. Microwaves May Provide Early Detection Of Breast Cancer
8. Learning From Experience: New Pattern Recognition & Detection Helps Radiologists Analyze Digital Mammograms
9. Could autoantibodies predict future disease in healthy people?
10. Mouse antibodies thwart SARS virus
11. Autoantibodies precede disease in lupus patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2019)... ... July 23, 2019 , ... Shady Grove Fertility (SGF) ... grand opening of its newest full-service fertility and in vitro fertilization (IVF) program in ... full-service location offers access to two leading, board certified reproductive endocrinologists, a state-of-the-art laboratory, ...
(Date:7/21/2019)... ... ... Surgical facelifts might be the gold standard for lifting facial skin and ... needs surgery, according to cosmetic surgeon Dr. Richard E. Buckley, medical director of MilfordMD ... who can’t tolerate the downtime associated with a surgical facelift, don’t want surgery or ...
(Date:7/18/2019)... ... July 18, 2019 , ... ... officials in Congress about new bills to protect patients from unexpected out-of-network medical ... People from Surprise Medical Bills Act ( H.R. 3502 ), introduced in the ...
(Date:7/18/2019)... ... July 18, 2019 , ... For the fourth ... Atlanta, Magazine’s list of “Top Doctors” issue. Deutsch is a double-board-certified plastic and, ... With specialized training from MD Anderson Cancer Center and Albert Einstein, Montefiore Medical ...
(Date:7/17/2019)... ... 17, 2019 , ... The FDA has cleared the "truSculpt® flex" ... to eight body areas simultaneously. Dr. Dennis Dass says the truSculpt® flex ... than previous muscle toning devices or conventional exercise. , “The truSculpt® flex is FDA-cleared ...
Breaking Medicine News(10 mins):
(Date:7/23/2019)... (PRWEB) , ... July 23, 2019 , ... ... its sixth physical rehabilitation hospital in the ever-growing Liberty Township (N. Cincinnati), Ohio ... acres, just north of Cincinnati, Ohio. The hospital site is located at the ...
(Date:7/23/2019)... ... July 23, 2019 , ... Breathe Life , a ... Hill , Partner at Diagram Ventures , has joined its board of directors. ... building and scaling early-stage technology businesses to the Breathe Life board at a time ...
(Date:7/23/2019)... ... July 23, 2019 , ... ... needs in the field of urology, today announced that Samuel Dakil, MD, Norman ... Excellence. The designation recognizes that Dr. Dakil has achieved a high level of ...
Breaking Medicine Technology:
Cached News: